Flowable Hemostats Market Poised to Grow at 7.1% CAGR Through 2032: Rising Surgical Cases and Aging Population to Drive Demand

The global flowable hemostats market is projected to rise from USD 912.2 million in 2021 to USD 1,124 million in 2022, and further grow at a CAGR of 7.1% to reach USD 1,654.25 million by 2032. This significant growth is being driven by an increasing number of trauma and surgical cases, the rise in chronic conditions among the aging population, and advancements in minimally invasive surgical procedures.

Flowable hemostats are advanced medical instruments designed to control bleeding during complex surgeries. Their ability to flow and adhere to moist surfaces makes them ideal for hard-to-reach surgical sites, especially in procedures involving the spine, heart, and abdomen. As healthcare systems worldwide evolve and demand for safer, more effective surgical tools increases, flowable hemostats are becoming a preferred solution across both developed and developing nations.

Browse for Full Report: https://www.factmr.com/report/flowable-hemostats-market

Key Market Drivers

Rising Surgical & Trauma Cases:
Trauma-related bleeding is a leading cause of death globally. According to the WHO, approximately 1.25 million people die annually due to traffic-related incidents, with hemorrhage accounting for over 40% of these deaths within the first 24 hours. Additionally, battlefield data suggests that 25% of fatalities could be prevented through effective bleeding control-90% of which are due to uncontrolled hemorrhage. These statistics underscore the growing need for efficient hemostatic solutions.

Growing Geriatric Population:
The aging population is a critical factor driving demand for flowable hemostats. Elderly individuals are more susceptible to chronic illnesses and often require surgeries for cardiovascular, orthopedic, and respiratory conditions. The WHO estimates that the global elderly population will reach 1.5 billion by 2050. Industrialized nations such as the U.S., U.K., and Japan, where healthcare access is improving, are witnessing an increasing adoption of these hemostats to support their aging demographics.
Regional Outlook

North America leads the global market and is anticipated to grow at a 6.9% CAGR through 2032. The region benefits from advanced healthcare systems, a high volume of surgical procedures, and strong R&D capabilities. U.S.-based companies such as Medcura have developed innovative solutions like Life Foam-an injectable hemostat for treating non-compressible abdominal wounds, especially relevant in trauma and battlefield scenarios. The FDA's Breakthrough Device Designation has further boosted innovation and adoption.

Asia Pacific, on the other hand, is expected to grow at a 6.7% CAGR, driven by increased hospital infrastructure, rising awareness about bleeding disorders, and a surge in surgical procedures. China is at the forefront, with a growing focus on treating hemophilia and related disorders. The Hemophilia Treatment Center Collaboration Network of China (HTCCNC) identified over 17,000 cases of hemophilia A between 2007 and 2019, highlighting the urgency for effective hemostatic solutions.

Segmental Insights

Material Analysis:
Bovine gelatin-based flowable hemostats are poised to dominate, accounting for 45.5% market share in 2022, and expected to grow at a 7.2% CAGR through 2032. Bovine gelatin, rich in amino acids and connective tissue building properties, is widely used in medical formulations.

End-User Analysis:
Hospitals and clinics are the largest end-users, projected to grow at a 7.4% CAGR and account for 34% of market share in 2022. These institutions rely heavily on flowable hemostats for procedures ranging from general surgeries to neuro and cardiac interventions, furthering demand.

Competitive Landscape

The global market is characterized by a strong presence of key players including:

Johnson & Johnson
Baxter International
Teleflex Incorporated
CR Bard, Inc.
Ethicon, Inc.
Axio Biosolutions
Pfizer, Inc.
Z-Medica LLC
Gelita Medical GmbH
Braun Melsungen AG
Marine Polymer Technologies, Inc.
Integra LifeSciences
Noteworthy developments include:

Axio Biosolutions, an Indian MedTech company and subsidiary of Advamedica Inc. (Boston), raised $6 million in Series B2 funding to expand its hemostatic product portfolio.

Baxter International Inc. received FDA approval to simplify its Floseal Hemostatic Matrix preparation by reducing steps by 20%, enhancing usability in surgical settings.

Baxter also completed the acquisition of CryoLife's PerClot Polysaccharide Hemostatic System, strengthening its surgical innovations portfolio.

Want a Sample Before Buying? Download Free Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=8094

Challenges

Despite strong growth, the market faces obstacles in developing nations due to lack of awareness about bleeding disorders such as Von Willebrand disease (VWD). An estimated 3 million individuals with VWD go untreated globally, particularly in countries like India and China. Educational outreach and infrastructure development remain vital to unlocking these markets.

Start-Up Landscape

Emerging companies like Kenyon USA and World Monopler Enterprises are contributing to the market with innovations in surgical tools and disposable medical devices. Their product lines, including hemostats, reflect a growing trend toward accessible and affordable surgical solutions.

The global flowable hemostats market is set on a growth trajectory fueled by increasing surgical needs, aging populations, and continual innovations in surgical technologies. With significant contributions from North America and emerging demand from Asia Pacific, the market promises lucrative opportunities for manufacturers, healthcare providers, and investors alike.

Check out More Related Studies Published by Fact.MR Research:

Welding Chemicals Market: https://www.factmr.com/report/3116/welding-chemicals-market

Pediatrics Orthotics Market: https://www.factmr.com/report/3125/pediatrics-orthotics-market

Aircraft Nacelle Components Market: https://www.factmr.com/report/3134/aircraft-nacelle-components-market

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : sales@factmr.com

About Us:

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

This release was published on openPR.